FAST NEWS: Clover Bio slumps after booting from China-Hong Kong Stock Connect
The latest: The Shanghai and Shenzhen stock exchanges removed Clover Biopharmaceuticals Ltd. (2197.HK) from their list of securities eligible for trading in the Hong Kong-China Stock Connect program, as part of…
With healthier finances, Clover Bio shifts to flu and RSV vaccines
The Chinese vaccine developer rebounded from a deep loss into profit in the first half of the year, boosted by a one-off gain from a Covid research grant Key Takeaways:…
FAST NEWS: Clover Bio Gets Exclusive Rights for Imported Flu Vaccine
The latest: Clover Biopharmaceuticals Ltd. (2197.HK) said on Monday it has reached an exclusive agreement to import Adimmune Corp.’s quadrivalent seasonal influenza vaccine AdimFlu-S (QIS) to China. It added it will…
Clover Biopharma Gets Critical Cash Booster After Covid Vaccine Approval
The innovative drug maker announced a major share sale a day after its self-developed Covid-19 vaccine got the green light for emergency use in ChinaKey Takeaways:Clover Biopharmaceuticals raised $64 million…
Surging Beigene Catches Case of Forex Flu
The drug maker’s net loss grew in the third quarter due to weakness in the Chinese yuan, even as its revenue nearly doubledKey Takeaways:Surging sales for its two self-developed drugs…
FAST NEWS: Clover to Complete Covid Vaccine Applications by Year-End
The latest: Clover Biopharmaceuticals Ltd. (2197.HK) said on Sunday it plans to complete registration applications for its lead Covid-19 vaccine candidate, SCB-2019, with the China National Medical Products Administration, the…
Recent Articles
RELATED ARTICLES
-
Stock disconnect triggers investor exodus from CStone Pharma
2616.HK - CHINA BULLETIN: China-U.S. Rapprochement Continues with Xi-Biden Call, Yellen Visit
- Facing anemic trading, Hong Kong considers staying open in foul weather
-
Haitong International gets set to bow from the Hong Kong Stock Exchange
6837.HK 600837.SHG
-
Stimulus moves give China and Hong Kong stocks a lift
0388.HK FXI.US
